相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning
John N. Ratchford et al.
NEUROLOGY (2013)
Pathology of Multiple Sclerosis
Markus Kipp et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)
Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
Bibiana Bielekova et al.
PLOS ONE (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Lars Bornsen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Mohsen Khademi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Validation of new biomarkers in systemic autoimmune diseases
Maria G. Tektonidou et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
Johannes Brettschneider et al.
PLOS ONE (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
M. Khademi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Disease Biomarkers in Multiple Sclerosis Potential for Use in Therapeutic Decision Making
Violaine K. Harris et al.
MOLECULAR DIAGNOSIS & THERAPY (2009)
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
E. Iacobaeus et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F. Sellebjerg et al.
NEUROLOGY (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Osteopontin: Role in immune regulation and stress responses
Kathryn X. Wang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Relapses in multiple sclerosis are age- and time-dependent
H. Tremlett et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis
Edgar Meinl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis
Bettina Kuenz et al.
PLOS ONE (2008)
Progression in multiple sclerosis: Further evidence of an age dependent process
Marcus Koch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2007)
Matrix metalloproteinase-9 and autoimmune diseases
Maya Ram et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Clinical characteristics and long term prognosis in early onset multiple sclerosis
Olivier Deryck et al.
JOURNAL OF NEUROLOGY (2006)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
Natural history of multiple sclerosis: a unifying concept
C Confavreux et al.
BRAIN (2006)
Disability progression in multiple sclerosis is slower than previously reported
H Tremlett et al.
NEUROLOGY (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis
C Tortorella et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Intrinsic versus environmental influences on T-cell responses in aging
PJ Linton et al.
IMMUNOLOGICAL REVIEWS (2005)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system
F Sellebjerg et al.
BRAIN RESEARCH BULLETIN (2003)
Three or more routes for leukocyte migration into the central nervous system
RM Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis
AI Danilov et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Age-related disability in multiple sclerosis
M Trojano et al.
ANNALS OF NEUROLOGY (2002)
Osteopontin - a molecule for all seasons
M Mazzali et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2002)
Chemokine receptor expression on B cells and effect of interferon-beta in multiple sclerosis
TL Sorensen et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Orthogonal projections to latent structures (O-PLS)
J Trygg et al.
JOURNAL OF CHEMOMETRICS (2002)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability
N De Stefano et al.
ARCHIVES OF NEUROLOGY (2001)
Human immunosenescence:: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space
C Franceschi et al.
VACCINE (2000)
分享论文
